PodBrowser
0x Research

Grading Citrini's Viral Crypto Portfolio

Wednesday, 14 October 2026 · 4 min read · Listen to the episode ↗

The panel grades Citrini’s crypto portfolio, questioning whether its weights match conviction and risk while debating its tilt toward derivatives and real-world assets. Hyperliquid emerges as the strongest candidate for a larger allocation, though its valuation has risen; speakers also scrutinize Derive’s illiquidity and revenue multiple, Aave’s competition, and Ethena’s dependence on funding yields and incentives. They differ on Solana’s role and remain divided on how much near-term market volatility to expect.

Citrini’s portfolio drew praise for targeting derivatives, lending, and other growth themes, but the panel questioned whether its weights match conviction and risk. Luke remains bullish over the next one to three years, citing a high-time-frame uptrend and bullish consolidation, while allowing for near-term chop and a delayed monthly higher low. Kunal would welcome a dip below $80,000 as a buying opportunity and said institutional interest, particularly in tokenized assets, is strong. Speakers also cautioned that the basket may be an RWA-focused thematic portfolio rather than a complete picture of crypto.

Hyperliquid emerged as the clearest candidate for a larger allocation. Speakers described HYPE as exposure not only to perpetuals, but also to spot, outcomes, borrowing, stablecoins, and tokenized equities and commodities; one called Hyperliquid a specialized financial L1, while another viewed it primarily as a perps DEX. They emphasized liquidity and value accrual, including a claim that the platform receives 90% of the yield from assets on it. Luke called HYPE his top holding, and one speaker proposed a 25% allocation, while another preferred about 15%; both thought it should be the portfolio’s largest position and exceed Derive. Citrini’s more balanced approach was defended as a reason not to go to 25%. HYPE’s multiples are historically elevated after its run-up, though speakers argued FDV may overstate near-term supply risk and said TradFi buyers could emerge. Citrini reportedly has 2% HYPE exposure through an ETF or DAF.

The 10% Derive allocation was considered large for an illiquid token, despite Luke’s high conviction. Kunal said its slightly more than $500,000 in revenue over the last 30 days implies about $6 million annualized and a roughly 100x multiple. He called that rich, attributed much of the recent price rise to Upbit volume, and warned that activity-dependent tokens can fall sharply when volume fades; another options venue on Hyperliquid is a further risk. Speakers see options gaining traction as traders seek longer-term leveraged exposure without liquidation risk, but noted that options exposure is already possible on Hyperliquid and that Jeff’s comment about building options was hypothetical. Citrini assigns Lighter a larger weight than Hyperliquid, a choice Shonda questioned given Hyperliquid’s maturity and broader narratives. Together, Lighter and Hyperliquid make up about 17% exposure to leading perpetual DEXs, with Ethena adding to the portfolio’s perps tilt. Citrini presents Lighter as a bet on derivatives growth, not on it displacing Hyperliquid. A possible Robinhood use of Lighter for US crypto perpetuals after regulatory clearance could make its sell-off a buying opportunity, and Lighter has options planned.

The 9% Aave allocation also drew scrutiny: one speaker cited a roughly 42x multiple, while Luke preferred a basket of lenders over a single-ticker bet. He is constructive on on-chain lending over the next few years, arguing that rising Bitcoin, Ether, and Solana prices could expand collateral and borrowing capacity. Aave has about 55% of active-loan market share, much backed by Bitcoin and Ether, and yield-bearing real-world assets could eventually support loan-to-deposit ratios of 50–80%. But Morpho is gaining share through distribution and partnerships, including Robinhood, potentially forcing Aave to improve incentives. One speaker expected Aave revenue to rise if markets keep rallying but doubted it would reach its previous-cycle high, preferring equal exposure to Aave, Morpho, Camino, and Syrup. Luke said contango in Boros term structure signals higher future perpetual and lending rates. He sees tokenized equities as weaker collateral for now, with lower money-market utilization and DEX activity driven largely by meme-stock pairs and arbitrage; he prefers AMMs such as Uniswap, Raydium, and Meteora for that theme.

Ethena’s 9% weight split the panel. Its bull case depends on a risk-on market lifting funding rates, USDe yields, and TVL, with buybacks directing value to ENA and the supply overhang apparently cleared. A critic prefers Ether.fi, arguing Ethena is valued at about five times Ether.fi on an fTV basis despite Ether.fi’s card traction and users, and doubting funding yields will return to prior highs as markets become more efficient. The critic said early USDe growth relied heavily on incentives and integrations that enabled looping; at one point about 1% of USDe was deployed in the strategy and 99% held as a stablecoin, versus about 20% deployed now. Ethena’s HIP-3 deployment was wound down, whitelisted stablecoins have grown little, and distributor economics leave limited value for the infrastructure layer, although Ethena Pay was seen as a compelling neobank narrative. Looping becomes attractive above roughly 8–9% yields; current USD yields just above 5% are insufficient. One speaker thought USDe yields might clear that threshold if Bitcoin reaches $120,000–$140,000, but said substantial TVL growth and card contributions are already priced in. Shonda said Pendle Sats incentives once pushed implied rates above underlying APY, with as much as 70% of supply in Pendle markets; without campaigns, premiums may not return to prior highs, though stronger basis APY could still grow supply.

The 8% Solana weight was acceptable to some but not all. Luke favors SOL over ETH and considers the allocation reasonable; Shonda has no SOL in her own portfolio but cited spot volume, RWA activity, and narratives. A critic said its long-term role remains unclear, X402 agentic payments are a tiny share of transactions, and Pump accounts for much of Solana’s volume and fees; omitting Pump misses a revenue-generating way to express the “long degeneracy” theme.

This summary was generated from the episode transcript and can contain mistakes.